These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17002217)

  • 41. Synaptic plasticity, AMPA-R trafficking, and Ras-MAPK signaling.
    Gu Y; Stornetta RL
    Acta Pharmacol Sin; 2007 Jul; 28(7):928-36. PubMed ID: 17588327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of AMPA receptors and synaptic plasticity.
    Santos SD; Carvalho AL; Caldeira MV; Duarte CB
    Neuroscience; 2009 Jan; 158(1):105-25. PubMed ID: 18424006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetic mechanism of channel opening of the GluRDflip AMPA receptor.
    Li G; Sheng Z; Huang Z; Niu L
    Biochemistry; 2005 Apr; 44(15):5835-41. PubMed ID: 15823042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Molecular mechanisms for memory formation].
    Manabe T
    Brain Nerve; 2008 Jul; 60(7):707-15. PubMed ID: 18646610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The AMPA modulator S 18986 improves declarative and working memory performances in aged mice.
    Marighetto A; Valerio S; Jaffard R; Mormede C; Muñoz C; Bernard K; Morain P
    Behav Pharmacol; 2008 May; 19(3):235-44. PubMed ID: 18469541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel class of AMPA receptor allosteric modulators. Part 1: design, synthesis, and SAR of 3-aryl-4-cyano-5-substituted-heteroaryl-2-carboxylic acid derivatives.
    Fernandez MC; Castaño A; Dominguez E; Escribano A; Jiang D; Jimenez A; Hong E; Hornback WJ; Nisenbaum ES; Rankl N; Tromiczak E; Vaught G; Zarrinmayeh H; Zimmerman DM
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5057-61. PubMed ID: 16879964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms for regulation of AMPAR trafficking by PICK1.
    Hanley JG
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):931-5. PubMed ID: 17052230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular mechanisms of neurite growth with AMPA receptor potentiation.
    Voss OP; Milne S; Sharkey J; O'Neill MJ; McCulloch J
    Neuropharmacology; 2007 Feb; 52(2):590-7. PubMed ID: 17101156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins.
    Elias GM; Nicoll RA
    Trends Cell Biol; 2007 Jul; 17(7):343-52. PubMed ID: 17644382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
    Howells FM; Russell VA
    Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In search of novel AMPA potentiators.
    Francotte P; de Tullio P; Fraikin P; Counerotte S; Goffin E; Pirotte B
    Recent Pat CNS Drug Discov; 2006 Nov; 1(3):239-46. PubMed ID: 18221205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AMPA receptor potentiators: application for depression and Parkinson's disease.
    O'Neill MJ; Witkin JM
    Curr Drug Targets; 2007 May; 8(5):603-20. PubMed ID: 17504104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease.
    Yamada KA
    Expert Opin Investig Drugs; 2000 Apr; 9(4):765-78. PubMed ID: 11060708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy.
    Harms JE; Benveniste M; Maclean JK; Partin KM; Jamieson C
    Neuropharmacology; 2013 Jan; 64(1):45-52. PubMed ID: 22735771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.
    Jamieson C; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Martin F; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6072-5. PubMed ID: 20817521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glutamate receptor plasticity at excitatory synapses in the brain.
    Genoux D; Montgomery JM
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1058-63. PubMed ID: 17714094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure based evolution of a novel series of positive modulators of the AMPA receptor.
    Jamieson C; Maclean JK; Brown CI; Campbell RA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L
    Bioorg Med Chem Lett; 2011 Jan; 21(2):805-11. PubMed ID: 21190850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
    Amargós-Bosch M; Adell A; Artigas F
    J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
    Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
    Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AMPA receptor-mediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures.
    Ménard C; Patenaude C; Gagné AM; Massicotte G
    J Neurosci Res; 2009 Mar; 87(4):876-86. PubMed ID: 18951489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.